|
1
|
Hou W, Liu B and Xu H: Celastrol:
Progresses in structure-modifications, structure-activity
relationships, pharmacology and toxicology. Eur J Med Chem.
189(112081)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen SR, Dai Y, Zhao J, Lin L and Wang Y
and Wang Y: A mechanistic overview of triptolide and celastrol,
natural products from Tripterygium wilfordii Hook F. Front
Pharmacol. 9(104)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang SF, Wu MY, Cai CZ, Li M and Lu JH:
Autophagy modulators from traditional Chinese medicine: Mechanisms
and therapeutic potentials for cancer and neurodegenerative
diseases. J Ethnopharmacol. 194:861–876. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mizushima N: Autophagy: Process and
function. Genes Dev. 21:2861–2873. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wei YM, Wang YH, Xue HQ, Luan ZH, Liu BW
and Ren JH: Triptolide, a Potential autophagy modulator. Chin J
Integr Med. 25:233–240. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Denton D and Kumar S: Autophagy-dependent
cell death. Cell Death Differ. 26:605–616. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Levine B and Kroemer G: Biological
functions of autophagy genes: A disease perspective. Cell.
176:11–42. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nixon RA: The role of autophagy in
neurodegenerative disease. Nat Med. 19:983–997. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Yang Y, Zheng L, Zheng X and Ge L:
Autophagosomal membrane origin and formation. Adv Exp Med Biol.
1208:17–42. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kaushal GP, Chandrashekar K, Juncos LA and
Shah SV: Autophagy function and regulation in kidney disease.
Biomolecules. 10(100)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shaid S, Brandts CH, Serve H and Dikic I:
Ubiquitination and selective autophagy. Cell Death Differ.
20:21–30. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Geisler S, Holmstrom KM, Skujat D, Fiesel
FC, Rothfuss OC, Kahle PJ and Spinger W: PINK1/Parkin-mediated
mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol.
12:119–131. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Martinez-Lopez N, Garcia-Macia M, Sahu S,
Athonvarangkul D, Liebling E, Merlo P, Cecconi F, Schwartz GJ and
Singh R: Autophagy in the CNS and periphery coordinate lipophagy
and lipolysis in the brown adipose tissue and liver. Cell Metab.
23:113–127. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li W, He P, Huang Y, Li YF, Lu J, Li M,
Kurihara H, Lou Z, Meng T, Onishi M, et al: Selective autophagy of
intracellular organelles: Recent research advances. Theranostics.
11:222–256. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dikic I and Elazar Z: Mechanism and
medical implications of mammalian autophagy. Nat Rev Mol Cell Biol.
19:349–364. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fleming A, Bourdenx M, Fujimaki M,
Karabiyik C, Krause GJ, Lopez A, Martín-Segura A, Puri C, Scrivo A,
Skidmore J, et al: The different autophagy degradation pathways and
neurodegeneration. Neuron. 110:935–966. 2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hu LF: Epigenetic regulation of autophagy.
Adv Exp Med Biol. 1206:221–236. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Guo J, Huang X, Wang H and Yang H:
Celastrol induces autophagy by targeting AR/miR-101 in prostate
cancer cells. PLoS One. 10(e0140745)2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Feng Y, Zhang B, Lv J, Zhang P, Mao Q, Lin
F, Zhao J, Fu X, Yang Y, Li Z, et al: Scaffold hopping of celastrol
provides derivatives containing pepper ring, pyrazine and oxazole
substructures as potent autophagy inducers against breast cancer
cell line MCF-7. Eur J Med Chem. 234(114254)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Boridy S, Le PU, Petrecca K and Maysinger
D: Celastrol targets proteostasis and acts synergistically with a
heat-shock protein 90 inhibitor to kill human glioblastoma cells.
Cell Death Dis. 5(e1216)2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu X, Zhao P, Wang X, Wang L, Zhu Y, Song
Y and Gao W: Celastrol mediates autophagy and apoptosis via the
ROS/JNK and Akt/mTOR signaling pathways in glioma cells. J Exp Clin
Cancer Res. 38(184)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li HY, Zhang J, Sun LL, Li BH, Gao HL, Xie
T, Zhang N and Ye ZM: Celastrol induces apoptosis and autophagy via
the ROS/JNK signaling pathway in human osteosarcoma cells: An in
vitro and in vivo study. Cell Death Dis. 6(e1604)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen Y, Ou Y, Tao Y, Liu H, Yin H, Zhong
S, Yu H, Zhao Z and He B: Effect and mechanisms of celastrol on the
apoptosis of HOS osteosarcoma cells. Oncol Rep. 40:2260–2268.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhao X, Gao S, Ren H, Huang H, Ji W and
Hao J: Inhibition of autophagy strengthens celastrol-induced
apoptosis in human pancreatic cancer in vitro and in vivo models.
Curr Mol Med. 14:555–563. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ren B, Liu H, Gao H, Liu S, Zhang Z,
Fribley AM, Callaghan MU, Xu Z, Zeng Q and Li Y: Celastrol induces
apoptosis in hepatocellular carcinoma cells via targeting
ER-stress/UPR. Oncotarget. 8:93039–93050. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Han X, Sun S, Zhao M, Cheng X, Chen G, Lin
S, Guan Y and Yu X: Celastrol stimulates hypoxia-inducible factor-1
activity in tumor cells by initiating the ROS/Akt/p70S6K signaling
pathway and enhancing hypoxia-inducible factor-1α protein
synthesis. PLoS One. 9(e112470)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lee HW, Jang KS, Choi HJ, Jo A, Cheong JH
and Chun KH: Celastrol inhibits gastric cancer growth by induction
of apoptosis and autophagy. BMB Rep. 47:697–702. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cai Z, Qian B, Pang J, Tan ZB, Zhao K and
Lei T: Celastrol induces apoptosis and autophagy via the AKT/mTOR
signaling pathway in the pituitary ACTH-secreting adenoma cells.
Curr Med Sci. 42:387–396. 2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang W, Wu Z, Qi H, Chen L, Wang T, Mao
X, Shi H, Chen H, Zhong M, Shi X, et al: Celastrol upregulated ATG7
triggers autophagy via targeting Nur77 in colorectal cancer.
Phytomedicine. 104(154280)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hu M, Luo Q, Alitongbieke G, Chong S, Xu
C, Xie L, Chen X, Zhang D, Zhou Y, Wang Z, et al: Celastrol-induced
Nur77 interaction with TRAF2 alleviates inflammation by promoting
mitochondrial ubiquitination and autophagy. Mol Cell. 66:141–153
e6. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Saber S, Abd El-Kader EM, Sharaf H,
El-Shamy R, El-Saeed B, Mostafa A, Ezzat D and Shata A: Celastrol
augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and
inducing autophagy in dextran sodium sulphate-induced colitis in
rats. Toxicol Appl Pharmacol. 400(115075)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yu X, Zhao Q, Zhang X and Zhang H, Liu Y,
Wu X, Li M, Li X, Zhang J, Ruan X and Zhang H: Celastrol
ameliorates inflammation through inhibition of NLRP3 inflammasome
activation. Oncotarget. 8:67300–67314. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhao J, Sun Y, Shi P, Dong JN, Zuo LG,
Wang HG, Gong JF, Li Y, Gu LL, Li N, et al: Celastrol ameliorates
experimental colitis in IL-10 deficient mice via the up-regulation
of autophagy. Int Immunopharmacol. 26:221–228. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Nie Y, Fu C, Zhang H, Zhang M, Xie H, Tong
X, Li Y, Hou Z, Fan X and Yan M: Celastrol slows the progression of
early diabetic nephropathy in rats via the PI3K/AKT pathway. BMC
Complement Med Ther. 20(321)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhan X, Yan C, Chen Y, Wei X, Xiao J, Deng
L, Yang Y, Qiu P and Chen Q: Celastrol antagonizes high
glucose-evoked podocyte injury, inflammation and insulin resistance
by restoring the HO-1-mediated autophagy pathway. Mol Immunol.
104:61–68. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wong VKW, Qiu C, Xu SW, Law BYK, Zeng W,
Wang H, Michelangeli F, Dias IRSR, Qu YQ, Chan TW, et al: Ca(2+)
signalling plays a role in celastrol-mediated suppression of
synovial fibroblasts of rheumatoid arthritis patients and
experimental arthritis in rats. Br J Pharmacol. 176:2922–2944.
2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lu X, Gong S, Wang X, Hu N, Pu D, Zhang J,
Wang Y, Luo J, An Q, Ju B and He L: Celastrol exerts
cardioprotective effect in rheumatoid arthritis by inhibiting
TLR2/HMGB1 signaling pathway-mediated autophagy. Int Arch Allergy
Immunol. 182:1245–1254. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Dai S, Fan J, Zhang Y, Hao Z, Yu H and
Zhang Z: Celastrol promotes chondrocyte autophagy by regulating
mTOR expression. Chin Med J (Engl). 135:92–94. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Feng K, Chen H and Xu C:
Chondro-protective effects of celastrol on osteoarthritis through
autophagy activation and NF-κB signaling pathway inhibition.
Inflamm Res. 69:385–400. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Deng YN, Shi J, Liu J and Qu QM: Celastrol
protects human neuroblastoma SH-SY5Y cells from rotenone-induced
injury through induction of autophagy. Neurochem Int. 63:1–9.
2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ng L, Wang X, Yang C, Su C, Li M and
Cheung AKL: Celastrol downmodulates alpha-Synuclein-specific T cell
responses by mediating antigen trafficking in dendritic cells.
Front Immunol. 13(833515)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lin MW, Lin CC, Chen YH, Yang HB and Hung
SY: Celastrol inhibits dopaminergic neuronal death of Parkinson's
disease through activating mitophagy. Antioxidants (Basel).
9(37)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Divya T, Sureshkumar A and Sudhandiran G:
Autophagy induction by celastrol augments protection against
bleomycin-induced experimental pulmonary fibrosis in rats: Role of
adaptor protein p62/SQSTM1. Pulm Pharmacol Ther. 45:47–61.
2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Shi Y, Jiang S, Zhao T, Gong Y, Liao D and
Qin L: Celastrol suppresses lipid accumulation through LXRα/ABCA1
signaling pathway and autophagy in vascular smooth muscle cells.
Biochem Biophys Res Commun. 532:466–474. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Xu XJ, Zhao WB, Feng SB, Sun C, Chen Q, Ni
B and Hu HY: Celastrol alleviates angiotensin II mediated vascular
smooth muscle cell senescence via induction of autophagy. Mol Med
Rep. 16:7657–7664. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Shi YN, Liu LP, Deng CF, Zhao TJ, Shi Z,
Yan JY, Gong YZ, Liao DF and Qin L: Celastrol ameliorates vascular
neointimal hyperplasia through Wnt5a-involved autophagy. Int J Biol
Sci. 17:2561–2575. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Du Z, Zhang W, Wang S, Zhang J, He J, Wang
Y, Dong Y and Huo M: Celastrol protects human retinal pigment
epithelial cells against hydrogen peroxide mediated oxidative
stress, autophagy, and apoptosis through sirtuin 3 signal pathway.
J Cell Biochem. 120:10413–10420. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Guo J, Mei Y, Li K, Huang X and Yang H:
Downregulation of miR-17-92a cluster promotes autophagy induction
in response to celastrol treatment in prostate cancer cells.
Biochem Biophys Res Commun. 478:804–810. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhang CJ, Zhu N, Long J, Wu HT, Wang YX,
Liu BY, Liao DF and Qin L: Celastrol induces lipophagy via the
LXRα/ABCA1 pathway in clear cell renal cell carcinoma. Acta
Pharmacol Sin. 42:1472–1485. 2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Xu SW, Law BYK, Qu SLQ, Hamdoun S, Chen J,
Zhang W, Guo JR, Wu AG, Mok SWF, Zhang DW, et al: SERCA and
P-glycoprotein inhibition and ATP depletion are necessary for
celastrol-induced autophagic cell death and collateral sensitivity
in multidrug-resistant tumor cells. Pharmacol Res.
153(104660)2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Wang WB, Feng LX, Yue QX, Wu WY, Guan SH,
Jiang BH, Yang M, Liu X and Guo DA: Paraptosis accompanied by
autophagy and apoptosis was induced by celastrol, a natural
compound with influence on proteasome, ER stress and Hsp90. J Cell
Physiol. 227:2196–2206. 2012.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Dai CH, Zhu LR, Wang Y, Tang XP, Du YJ,
Chen YC and Li J: Celastrol acts synergistically with afatinib to
suppress non-small cell lung cancer cell proliferation by inducing
paraptosis. J Cell Physiol. 236:4538–4554. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Nazim UM, Yin H and Park SY: Autophagy
flux inhibition mediated by celastrol sensitized lung cancer cells
to TRAIL induced apoptosis via regulation of mitochondrial
transmembrane potential and reactive oxygen species. Mol Med Rep.
19:984–993. 2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Xu SW, Law BY, Mok SW, Leung EL, Fan XX,
Coghi PS, Zeng W, Leung CH, Ma DL and Liu Land Wong VK: Autophagic
degradation of epidermal growth factor receptor in
gefitinib-resistant lung cancer by celastrol. Int J Oncol.
49:1576–1588. 2016.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Duan J, Zhan JC, Wang GZ, Zhao XC, Huang
WD and Zhou GB: The red wine component ellagic acid induces
autophagy and exhibits anti-lung cancer activity in vitro and in
vivo. J Cell Mol Med. 23:143–154. 2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Wang L, Tang L, Yao C, Liu C and Shu Y:
The synergistic effects of celastrol in combination with tamoxifen
on apoptosis and autophagy in MCF-7 Cells. J Immunol Res.
2021(5532269)2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Liu M, Fan Y, Li D, Han B, Meng Y, Chen F,
Liu T, Song Z, Han Y, Huang L, et al: Ferroptosis inducer erastin
sensitizes NSCLC cells to celastrol through activation of the
ROS-mitochondrial fission-mitophagy axis. Mol Oncol. 15:2084–2105.
2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Yang C, Su C, Iyaswamy A, Krishnamoorthi
SK, Zhu Z, Yang S, Tong BC, Liu J, Sreenivasmurthy SG, Guan X, et
al: Celastrol enhances transcription factor EB (TFEB)-mediated
autophagy and mitigates Tau pathology: Implications for Alzheimer's
disease therapy. Acta Pharm Sin B. 12:1707–1722. 2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Zhang C, Wang R, Liu Z, Bunker E, Lee S,
Giuntini M, Chapnick D and Liu X: The plant triterpenoid celastrol
blocks PINK1-dependent mitophagy by disrupting PINK1's association
with the mitochondrial protein TOM20. J Biol Chem. 294:7472–7487.
2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Kocaturk NM, Akkoc Y, Kig C, Bayraktar O,
Gozuacik D and Kutlu O: Autophagy as a molecular target for cancer
treatment. Eur J Pharm Sci. 134:116–137. 2019.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Kessel D: Apoptosis, paraptosis and
autophagy: Death and survival pathways associated with photodynamic
therapy. Photochem Photobiol. 95:119–125. 2019.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Kusy S, Ghosn EE, Herzenberg LA and Contag
CH: Development of B cells and erythrocytes is specifically
impaired by the drug celastrol in mice. PLoS One.
7(e35733)2012.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Zhang J, Shan J, Chen X, Li S, Long D and
Li Y: Celastrol mediates Th17 and Treg cell generation via
metabolic siganling. Biochem Biophys Res Commun. 497:883–889.
2018.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Deretic V: Autophagy in inflammation,
infection, and immunometabolism. Immunity. 54:437–453.
2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Gurung P, Lukens JR and Kanneganti TD:
Mitochondria: diversity in the regulation of the NLRP3
inflammasome. Trends Mol Med. 21:193–201. 2015.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Sawaf H, Thomas G, Taliercio JJ, Nakhoul
G, Vachharajani TJ and Mehdi A: Therapeutic advances in diabetic
nephropathy. J Clin Med. 11(378)2022.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Cush JJ: Rheumatoid arthritis: Early
diagnosis and treatment. Rheum Dis Clin North Am. 48:537–547.
2022.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Zhou Z, Miao Z, Luo A, Zhu D, Lu Y, Li P,
Feng X, Tan W and Wang F: Identifying a marked inflammation
mediated cardiac dysfunction during the development of arthritis in
collagen-induced arthritis mice. Clin Exp Rheumatol. 38:203–211.
2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Hosseinzadeh A, Kamrava SK, Joghataei MT,
Darabi R, Shakeri-Zadeh A, Shahriari M, Reiter RJ, Ghaznavi H and
Mehrzadi S: Apoptosis signaling pathways in osteoarthritis and
possible protective role of melatonin. J Pineal Res. 61:411–425.
2016.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Fujikake N, Shin M and Shimizu S:
Association between autophagy and neurodegenerative diseases. Front
Neurosci. 12(255)2018.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Wei YM and Han B: Beclin1 decreases the
RIPA-insoluble fraction of amyotrophic lateral sclerosis-linked
SOD1 mutant via autophagy. Neurosci Lett. 690:106–111.
2019.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Zhang L, Cheng S, Jiang X, Zhang J, Meng
P, Tang Q, Qin X, Wang B, Chen C and Zou Z: Pregnancy exposure to
carbon black nanoparticles exacerbates bleomycin-induced lung
fibrosis in offspring via disrupting LKB1-AMPK-ULK1 axis-mediated
autophagy. Toxicology. 425(152244)2019.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Zhou K, Chang Y, Han B, Li R and Wei Y:
MicroRNAs as crucial mediators in the pharmacological activities of
triptolide (Review). Exp Ther Med. 21(499)2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Frankel LB, Wen J, Lees M, Høyer-Hansen M,
Farkas T, Krogh A, Jäättelä M and Lund AH: microRNA-101 is a potent
inhibitor of autophagy. EMBO J. 30:4628–4641. 2011.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Martini-Stoica H, Xu Y, Ballabio A and
Zheng H: The autophagy-lysosomal pathway in neurodegeneration: A
TFEB perspective. Trends Neurosci. 39:221–234. 2016.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Martina JA, Chen Y, Gucek M and
Puertollano R: MTORC1 functions as a transcriptional regulator of
autophagy by preventing nuclear transport of TFEB. Autophagy.
8:903–914. 2012.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Zhu Z, Yang C, Iyaswamy A, Krishnamoorthi
S, Sreenivasmurthy SG, Liu J, Wang Z, Tong BC, Song J, Lu J, et al:
Balancing mTOR signaling and autophagy in the treatment of
Parkinson's disease. Int J Mol Sci. 20(728)2019.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Dai S, Wang H, Wang M, Zhang Y, Zhang Z
and Lin Z: Comparative transcriptomics and network pharmacology
analysis to identify the potential mechanism of celastrol against
osteoarthritis. Clin Rheumatol. 40:4259–4268. 2021.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Li Y and Chen Y: AMPK and autophagy. Adv
Exp Med Biol. 1206:85–108. 2019.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Gao L, Loveless J, Shay C and Teng Y:
Targeting ROS-mediated crosstalk between autophagy and apoptosis in
cancer. Adv Exp Med Biol. 1260:1–12. 2020.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Pohl C and Dikic I: Cellular quality
control by the ubiquitin-proteasome system and autophagy. Science.
366:818–822. 2019.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Yang H, Landis-Piwowar KR, Chen D, Milacic
V and Dou QP: Natural compounds with proteasome inhibitory activity
for cancer prevention and treatment. Curr Protein Pept Sci.
9:227–239. 2008.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Ji CH and Kwon YT: Crosstalk and interplay
between the ubiquitin-proteasome system and autophagy. Mol Cells.
40:441–449. 2017.PubMed/NCBI View Article : Google Scholar
|
